DOSSIER · 13F-HR · Q1 2026

Eversept Partners, LP

Eversept's holding co. based in New York, NY — $1.9B in tracked AUM across 120 positions as of Q1 2026.

E

Eversept·New York, NY·Holding Co.

CIK 0001697013 · last filed Mar 31, 2026

Total AUM

$1.9B

▼ 6.4%

vs prior

Holdings

120

—

positions

Whale Score

63

63

tracked

Activity

—

no data

changes this Q

Top sector

Tech

16% weight

concentration

AI Analysis · Q1 2026 · Q1 2026

Comprehensive Analysis of Eversept Partners, LP SEC 13F Filing

Portfolio Overview

Eversept Partners, LP manages a concentrated portfolio totaling $934.89 million across 54 holdings as of the report date September 30, 2025. The firm manages a highly specialized fund that underwent significant transformation during the quarter, evidenced by a 14.0% decrease in total portfolio value (down from $1.09 billion) and a massive turnover in holdings. The portfolio is characterized by hi...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

01

UNITED THERAPEUTICS CORP DEL

$157M264K8.3%

02

INVESCO QQQ TR

$138M239K7.3%

03

ABIVAX SA

$104M934K5.5%

04

GSK PLC

$99M1.8M5.2%

05

VERA THERAPEUTICS INC

$87M2.2M4.6%

06

NATERA INC

$77M385K4.1%

07

STATE STR SPDR S&P 500 ETF T

$70M107K3.7%

08

SYNDAX PHARMACEUTICALS INC

$67M2.9M3.6%

09

CELLDEX THERAPEUTICS INC NEW

$57M1.8M3.0%

10

VAXCYTE INC

$54M924K2.8%

Filing history

Filing history loading…